FDA Clearance Tracker · P850010-S082
Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic Sponge
Last checked: Nov 20, 2026Latest source record: Mar 13, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Mar 13, 2019
Approved
Time to decision
180 days
Received Sep 14, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P850010-S082
- Device name
- Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic Sponge
- Applicant
- Integra LifeSciences Corporation
- Applicant location
- Plainsboro, NJ
- Received
- Sep 14, 2018
- Decided
- Mar 13, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P850010
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
Approval for an additional trade name, OraFOAM, for the Helistat® Absorbable Collagen Hemostatic Sponge.
Source documents
Other decisions for Integra LifeSciences Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251162 · Decided Oct 8, 2025 · 176 days after receipt
Device type: Instrument, Ultrasonic Surgical (LFL) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.